Consumer Information for: APO-SOLIFENACIN
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
APO-SOLIFENACIN is used in the treatment of overactive bladder in adults with symptoms of frequent and urgent need to urinate (urinary frequency, urinary urgency) with urine leakage (urge urinary incontinence).
What it does
APO-SOLIFENACIN is a urinary antispasmodic medication that helps to relax the smooth muscle of the bladder which leads to reduction of the symptoms caused by overactive bladder
When it should not be used
You should not take APO-SOLIFENACIN:
- If you are not able to empty your bladder (also called urinary retention).
- If you have End-Stage Kidney Disease and require dialysis
- If you are not able to empty your stomach (also called gastroparesis).
- If you have narrow-angle glaucoma (high pressure and pain in the eyes).
- If you are allergic to solifenacin succinate or any of the other ingredients in APO-SOLIFENACIN. See ‘What the nonmedicinal ingredients are’
What the medicinal ingredient is
The medicinal ingredient in APO-SOLIFENACIN Tablet is ‘solifenacin succinate’.
What the non-medicinal ingredients are
Each APO-SOLIFENACIN tablet contains the following inert ingredients: anhydrous lactose, croscarmellose sodium, hydroxypropyl cellulose, magnesium stearate, polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, yellow iron oxide (5 mg APO-SOLIFENACIN tablet) and euroxide red iron oxide (10 mg APO-SOLIFENACIN tablet).
What dosage form it comes in
APO-SOLIFENACIN is available in 5 and 10 mg tablets
Warnings and precautions
Before you use APO-SOLIFENACIN, talk to your doctor or pharmacist if you:
- Have stomach problems affecting passage and digestion of food, or severe constipation.
- Have glaucoma.
- Have difficulty urinating, or weak urine stream.
- Have heart disease
- Have a rare heart problem called QT/QTc prolongation or family history of QT/QTc prolongation.
- Have kidney or liver problems.
- Have reduced ability to sweat.
- Are pregnant or planning to become pregnant. Women who might get pregnant should use an effective birth control method while taking APOSOLIFENACIN.
- Are breastfeeding or plan to breastfeed.
APO-SOLIFENACIN should not be given to children
or adolescents.
APO-SOLIFENACIN may cause blurred vision and
drowsiness. Do not drive a car, operate any
machinery, or engage in any activities that require
accurate vision and full attention.
In hot weather, APO-SOLIFENACIN can cause heat prostration (fever and heat stroke due to decreased sweating). Do not stay long in a hot environment while taking the drug. If you have any symptoms of heat prostration, keep yourself cool and drink a lot of water.
Angioedema (the symptoms include swelling of the face or tongue, difficulty breathing) and anaphylactic reactions (the symptoms include hives, difficulty breathing, abdominal cramps, rapid heartbeat and feeling faint), which could be life threatening, have been reported in some patients taking APOSOLIFENACIN. If you experience any of these symptoms, stop taking APO-SOLIFENACIN and see your doctor immediately.
Interactions with this medication
Before and while taking APO-SOLIFENACIN you should tell your doctor about your other medications, even the medicine you bought without prescription, including vitamins and herbal supplements.
APO-SOLIFENACIN is known to have drug interactions with the following drugs: Drugs known to prolong the QT/QTc interval and/or cause torsade de pointes, drugs that decrease electrolyte levels, anticholinergic drugs, drugs that stimulate the motility of the gut such as metoclopramide, ketoconazole, clarithromycin, erythromycin, diclofenac, nefazodone, verapamil.
Drinking grapefruit juice with APO-SOLIFENACIN may increase your blood level of solifenacin.
Proper use of this medication
Usual Dose
5 mg daily. The daily dose may be increased to 10 mg following consultation with your doctor. Swallow the tablet whole with water
APO-SOLIFENACIN tablets can be taken with or without food.
Overdose
Missed Dose
If a dose is missed, the next tablet should be taken as planned. Doses should not be doubled to make up for a missed dose.
Side effects and what to do about them
The following side effects have been reported in clinical trials with APO-SOLIFENACIN: Most common side effects: dry mouth and constipation Common side effects: dry eyes, urinary retention, blurred vision, nausea, abdominal pain, indigestion, urinary tract infection.
The following side effects have been reported with the use of APO-SOLIFENACIN in worldwide postmarketing experience, although the frequency of events or a causal relationship with APOSOLIFENACIN could not always be confirmed
acid reflux, change in sense of taste, decreased appetite, delirium, dizziness, dry skin, fast or irregular heartbeat, feeling sleepy, glaucoma, hallucination, headache, high potassium levels, hypersensitivity reactions, intestinal blockage, itchiness, kidney ailment, liver problems, muscle weakness, nasal dryness, voice disorder, severe skin
scaling and redness, itching (exfoliative dermatitis), severe skin rash, itchiness and fever (erythema multiforme), swelling in the lower limbs and vomiting
Tell your doctor or pharmacist if you have any side effects while taking APO-SOLIFENACIN. This includes any side effects not listed above.
Symptom / effect | Talk with your doctor, nurse, or pharmacist only if severe | Talk with your doctor, nurse, or pharmacist in all cases | Stop taking drug and talk with your doctor or pharmacist |
---|---|---|---|
Rare | |||
Abdominal pain | ✔ | ||
Constipation for more than 3 days | ✔ | ||
Urinary retention | ✔ | ||
Very rare | |||
Swelling of the face or tongue, difficulty breathing | ✔ | ||
Fast or irregular heartbeat | ✔ | ||
Anaphylactic reactions (severe allergic reactions) | ✔ |
How to store
Keep APO-SOLIFENACIN and all other medications out of the reach of children.
Store between 15oC to 30oC.
Do not keep medicine that is out of date or that you no longer need.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-healthproducts/medeffect-canada/adverse-reactionreporting.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
If you want more information about APOSOLIFENACIN:
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://health-products.canada.ca/dpdbdpp/index-eng.jsp). Find the Consumer Information on the manufacturer’s website (http://www.apotex.ca/products) or by calling 1-800-667-4708.
This leaflet was prepared by Apotex Inc., Toronto, Ontario, M9L 1T9.
Last revised: April 5, 2019
Related Drug Products
Product name | DIN | Company name | Active ingredient(s) & strength |
---|---|---|---|
PREVNAR 13 | 02335204 | PFIZER CANADA ULC | CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN 34 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B 4.4 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F 2.2 MCG / 0.5 ML PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V 2.2 MCG / 0.5 ML |